Suchergebnisse - (Subject:"Siltuximab")

PubPharm (226)

91

Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19

enthalten in: Infectious diseases and therapy | 2020

von Meletiadis, J. | Tsiodras, S. | Tsirigotis, P.

92

Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19

enthalten in: Infectious diseases and therapy | 2020

von Meletiadis, J. | Tsiodras, S. | Tsirigotis, P.

93

Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab : Infection Without Fever on Anti-Interleukin-6 Therapy

enthalten in: Cureus | 2020

von Cohen, P. | Nikanjam, M. | Kato, S. | +2

94

A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients

enthalten in: European review for medical and pharmacological sciences | 2020

von Solis-García Del Pozo, J. | Galindo, M. | Nava, E. | +1

95

Cytokine storm intervention in the early stages of COVID-19 pneumonia

enthalten in: Cytokine & growth factor reviews | 2020

von Sun, X. | Wang, T. | Cai, D. | +9

CommentIn: Cytokine Growth Factor Rev. 2021 Apr;58:30-31. - PMID 32873506

96

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID) : A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Maes, B. | Bosteels, C. | De Leeuw, E. | +14

ErratumIn: Trials. 2020 Jun 22;21(1):556. - PMID 32571394

97

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Maes, B. | Bosteels, C. | De Leeuw, E. | +14

98

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Maes, B. | Bosteels, C. | De Leeuw, E. | +14

99

Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition

enthalten in: Infectious disease clinics of North America | 2020

von Liu, A.

100

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response

enthalten in: Journal for immunotherapy of cancer | 2020

von Arnaldez, F. | O'Day, S. | Drake, C. | +8